COVID-19 Vaccine Hesitancy among the General Population: A Cross-Sectional Study

被引:3
|
作者
Abdalla, Sawsan Mustafa [1 ]
Mohamed, Elsadig Yousif [1 ]
Elsabagh, Hala Mostafa [2 ,3 ]
Ahmad, Mohammad Shakil [1 ]
Shaik, Riyaz Ahamed [1 ]
Mehta, Vini [4 ]
Mathur, Ankita [5 ]
Ghatge, Sharad Balasaheb [6 ,7 ]
机构
[1] Majmaah Univ, Coll Med, Dept Family & Community Med, Al Majmaah 11952, Saudi Arabia
[2] Majmaah Univ, Coll Dent, Basic Med Sci Dept, Al Majmaah 11952, Saudi Arabia
[3] Tanta Univ, Dept Publ Hlth & Community Med, Tanta 6632110, Egypt
[4] Dr DY Patil Dent Coll & Hosp, Dept Publ Hlth Dent, Dr DY Patil Vidyapeeth, Pune 411018, Maharashtra, India
[5] Dr DY Patil Dent Coll & Hosp, Dept Periodontol, Dr DY Patil Vidyapeeth, Pune 411018, Maharashtra, India
[6] Sir JJ Grp Hosp, Grant Govt Med Coll, Dept Radiol & Imaging, Div Intervent Radiol, Mumbai 400008, Maharashtra, India
[7] Bombay Hosp & Med Res Ctr, Dept Intervent Neuroradiol, Mumbai 400020, Maharashtra, India
关键词
vaccine; hesitancy; fear; mistrust;
D O I
10.3390/vaccines11061125
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Hesitancy about receiving vaccines has been deemed a global danger to public health by WHO. The sociocultural backgrounds of the people have an impact on vaccine acceptance. The purpose of this study was to examine the effect of sociodemographic factors on COVID-19 vaccination hesitancy as well as to identify the factors that contributed to COVID-19 vaccine hesitancy. Methods: A cross-sectional study was carried out to determine the primary variables causing COVID-19 vaccination hesitancy among residents of Pune. The general population was sampled through simple random sampling. The minimum sample size was determined to be 1246. The questionnaire inquired about the individuals' sociodemographic information, vaccination status, and reasons for vaccine hesitancy. Results: In total, there were 5381 subjects, 1669 of whom were unvaccinated and 3712 of whom were partially vaccinated. Fear of adverse effects (51.71%), fear of losing a few days of work (43.02%), and inability to secure a vaccine slot online (33.01%) were the most frequently cited reasons. An older population (>60 years, p = 0.004), males (p = 0.032), those who were literate (p = 0.011), those of lower middle socioeconomic status (p = 0.001), and smokers were significantly associated with fear and mistrust of the COVID-19 vaccine, while mistrust of the vaccine was greatest among individuals from the upper and lower middle classes (p = 0.001). Conclusion: Vaccine hesitancy due to concerns about the side effects and long-term complications was prevalent among the elderly, males, those from the lower middle class, and smokers. This study emphasizes the importance of communicating effectively about the vaccine's efficacy, its distribution, and vaccination sites.
引用
收藏
页数:14
相关论文
共 50 条
  • [31] COVID-19 vaccine hesitancy in multiple sclerosis: A cross-sectional survey
    Uhr, Lauren
    Mateen, Farrah J.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (07) : 1072 - 1080
  • [32] Frailty is an Independent Determinant of COVID-19 Vaccine Hesitancy in the Elderly: a Cross-sectional Study
    Xiong, Lu
    Han, Mei
    Wang, Chunmiao
    Liu, Kai
    Liu, Tao
    [J]. CELLULAR AND MOLECULAR BIOLOGY, 2022, 68 (04) : 202 - 207
  • [33] Determinants of COVID-19 vaccine acceptance and hesitancy: a cross-sectional study in Saudi Arabia
    Yahia, Amar Ibrahim Omer
    Alshahrani, Abdullah Mohammed
    Alsulmi, Wael Gabir H.
    Alqarni, Mohammed Mesfer M.
    Abdulrahim, Tamim Khalid Abdullah
    Heba, Waleed Faya H.
    Alqarni, Turki Ayidh A.
    Alharthi, Khalid Ali Z.
    Buhran, Abdullah Ali A.
    [J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2021, 17 (11) : 4015 - 4020
  • [34] Understanding COVID-19 vaccine hesitancy: A cross-sectional study in Malang District, Indonesia
    Sujarwoto, Asri
    Maharani, Asri
    Holipah
    Andarini, Sri
    Saputri, Rindi Ardika Melsalasa
    Pakpahan, Eduwin
    Oceandy, Delvac
    Tampubolon, Gindo
    [J]. FRONTIERS IN PUBLIC HEALTH, 2023, 10
  • [35] Covid-19 vaccination reported side effects and hesitancy among the Syrian population: a cross-sectional study
    Najjar, Michel
    Albuaini, Sara
    Fadel, Mohammad
    Mohsen, Fatema
    Data Collect Grp
    [J]. ANNALS OF MEDICINE, 2023, 55 (02)
  • [36] COVID-19 Vaccine Hesitancy Among Patients Recovered From COVID-19 Infection in Wuhan, China: Cross-Sectional Questionnaire Study
    Huang, Yiman
    Zhang, Ling
    Fu, Jiaqi
    Wu, Yijin
    Wang, Hao
    Xiao, Weijun
    Xin, You
    Dai, Zhenwei
    Si, Mingyu
    Chen, Xu
    Jia, Mengmeng
    Leng, Zhiwei
    Cui, Dan
    Su, Xiaoyou
    [J]. JMIR PUBLIC HEALTH AND SURVEILLANCE, 2023, 9
  • [37] COVID-19 booster dose acceptance, hesitancy and concerns among the elderly population: A cross-sectional study
    Imran, Muhammad
    Ahmed, Zeeshan
    Ishaqui, Azfar Athar
    Bafail, Duaa
    Ahmad, Salman Ashfaq
    Farooq, Javeria
    Ali, Imran
    Mustafa, Bilal
    Zehra, Tabassum
    Jaweed, Lailoona
    Kapadia, Samreen
    Ahmed, Salman
    Ahmed, Shayan
    Maqsood, Muhammad Bilal
    [J]. JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, 2023, 17 (11): : 1529 - 1536
  • [38] Predictors of vaccine hesitancy during the COVID-19 pandemic in Austria A population-based cross-sectional study
    Till, Benedikt
    Niederkrotenthaler, Thomas
    [J]. WIENER KLINISCHE WOCHENSCHRIFT, 2022, 134 (23-24) : 822 - 827
  • [39] Predictors of vaccine hesitancy during the COVID-19 pandemic in AustriaA population-based cross-sectional study
    Benedikt Till
    Thomas Niederkrotenthaler
    [J]. Wiener klinische Wochenschrift, 2022, 134 : 822 - 827
  • [40] Prevalence and correlates of COVID-19 vaccine hesitancy among Chinese myocardial infarction survivors: A cross-sectional study
    Lin, Yun
    Bai, Wei
    Su, Zhaohui
    Jackson, Todd
    Xiang, Yu-Tao
    [J]. PREVENTIVE MEDICINE REPORTS, 2023, 35